
Urine-derived cells (UDC) have been used to analyze genetic variants in patients with osteogenesis imperfecta (OI) and determine their pathogenicity. The study successfully cultured UDC from 40 participants, including those with OI or suspected OI. RNA sequencing of UDC revealed similar gene expression profiles to fibroblasts, with less variability than whole blood cells. The analysis identified abnormal splicing in participants with pathogenic variants and provided evidence for the pathogenicity of certain variants affecting splicing. Additionally, UDC transcripts also showed abnormal deletions and duplications. The findings suggest that UDC can be used for functional analysis of genetic variants in OI.
Like
Save
Share